BioInnovation logo

BioInnovation

North America, Massachusetts, United States, Cambridge

Description

BioInnovation LLC, based in Cambridge, Massachusetts, is an early stage life sciences investment and consulting firm.

Investor Profile

BioInnovation has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 30% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series A (50%)
  • Series Unknown (30%)
  • Seed (10%)
  • Series B (10%)

Country Focus

  • United States (80%)
  • Canada (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Wellness
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioInnovation frequently co-invest with?

Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
CV
North America, Massachusetts, United States, Boston
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
AgeChem Venture Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Mission BioCapital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
MBLVC
Asia, Aichi, Japan, Nagoya
Co-Investments: 1
Mass Medical Angels
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by BioInnovation?

Pandion Therapeutics

Cambridge, Massachusetts, United States

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BApr 1, 2020
Amount Raised: $80,000,000
Vaxess Technologies

Cambridge, Massachusetts, United States

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

BiotechnologyHealth CareMedical
Series AJun 27, 2019
Amount Raised: $8,200,000
Cereius

Durham, North Carolina, United States

Cereius is a pre-clinical stage company developing novel approaches to treat solid tumour brain metastasis.

Biotechnology
Series AJul 25, 2018
Amount Raised: $6,500,000
PanTher Therapeutics

Cambridge, Massachusetts, United States

PanTher Therapeutics features treatment platform designed to enhance therapeutic response with minimal side effects.

BiotechnologyMedicalTherapeutics
SeedFeb 23, 2018
Pandion Therapeutics

Cambridge, Massachusetts, United States

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series AJan 17, 2018
Amount Raised: $58,000,000
Avexegen Therapeutics

San Diego, California, United States

Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.

BiotechnologyTherapeutics
Series UnknownJan 1, 2018
Sentien Biotechnologies

Lexington, Massachusetts, United States

Sentien is a developer of new blood conditioning therapies designed to restore balance to the immune system of critically ill patients.

BiotechnologyHealth CareTherapeutics
Series AApr 4, 2017
Amount Raised: $12,000,000
Vaxess Technologies

Cambridge, Massachusetts, United States

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

BiotechnologyHealth CareMedical
Series UnknownJan 30, 2017
Amount Raised: $862,857
Chlorion Pharma

Quebec, Quebec, Canada

Chlorion Pharma is a company that specializes in the development of a new generation of small molecule therapeutics.

BiotechnologyPharmaceutical
Series UnknownOct 15, 2007
Amount Raised: $6,000,000
Pegase Medical

Quebec, Quebec, Canada

Pegase Medical Inc., a Quebec City-based developer of natural base products for the animal market.

Health CareMedical
Series AMay 31, 2007
Amount Raised: $2,804,522